Skip to main content

Animations

MJFF Publications

6021 - 6030 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2013
  • 2024
  • 2017
  • 2016
  • 2011
  • 2013
  • 2012
  • 2021
  • Summary Details
    OPEN
    Title: A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56833-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge
    Journal Name: PLOS Digital Health
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pdig.0000208
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized Seizures
    Journal Name: Human Mutation
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa, unspecified-oa
    DOI - Digital Object Identifier: 10.1002/humu.22372
    Citation Count: 315
  • Summary Details
    OPEN
    Title: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469
    Citation Count: 2
  • Summary Details
    OPEN
    Title: SAMTOR is an S -adenosylmethionine sensor for the mTORC1 pathway
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.aao3265
    Citation Count: 463
  • Summary Details
    OPEN
    Title: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0130-3
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Alzheimer's disease: Pathogenesis and prevention
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011
    Citation Count: 97
  • Summary Details
    OPEN
    Title: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01256-w
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.